Guangdong Taienkang Pharmaceutical News

Taienkang: Inspection opinions of Guotai Junan Securities Co., Ltd. on the adjustment of the internal investment structure, implementation location and project extension of some fund-raising projects of Guangdong Taiankang Pharmaceutical Co., Ltd.

Dec 13 19:26

Taienkang: Announcement on Adjusting the Internal Investment Structure, Implementation Location and Project Extension of Some Fund-raising Projects

Dec 13 19:26

Taienkang: Announcement of Resolutions of the 6th Meeting of the Fifth Board of Directors

Dec 13 19:26

Taienkang: Announcement of Resolutions of the 6th Meeting of the Fifth Board of Supervisors

Dec 13 19:26

Taienkang: Announcement on partial share pledges by controlling shareholders and actual controllers

Dec 10 17:00

Taienkang: Announcement on the completion of phase III clinical trial of pilocarpine hydrochloride eye drops, a wholly-owned subsidiary

Dec 2 19:24

Taienkang: Announcement on the receipt of a notice of acceptance of drug registration by a wholly-owned subsidiary

Nov 22 15:46

Taienkang: Investor Relations Activity Record Form for November 15, 2024

Nov 18 18:16

Taienkang: Announcement on the expiration of the repurchase period of the company\'s shares and the implementation results of the repurchase

Nov 1 16:42

Taienkang: Voluntary Disclosure Notice on the Progress of Clinical Trials of the Class 1 Innovative Drug CKBA Ointment developed by the holding subsidiary

Oct 31 18:10

Taienkang: Report for the third quarter of 2024

Oct 29 00:00

Taienkang: Announcement on the progress of the repurchase of the company\'s shares

Oct 8 16:06

Taienkang: Announcement on the receipt of a notice of acceptance of drug registration by a wholly-owned subsidiary

Sep 18 16:40

Taienkang: Investor Relations Activity Record Form for September 12, 2024

Sep 12 17:00

Taienkang: Announcement on participating in the 2024 Investor Online Group Reception Day in Guangdong

Sep 9 16:42

Taienkang: Announcement on the receipt of a notice of acceptance of drug registration by a wholly-owned subsidiary

Sep 9 16:42

Taienkang: Announcement on the progress of the repurchase of the company\'s shares

Sep 2 16:58

Taienkang: Investor Relations Activity Record Form for August 28, 2024

Aug 28 19:00

Taienkang: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024

Aug 28 00:00

Taienkang: Summary table of non-operating capital expenditure and other related capital transactions for the first half year of 2024

Aug 28 00:00